These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al. Morgan SL; Baggott JE; Alarcón GS Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062 [No Abstract] [Full Text] [Related]
24. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Whittle SL; Hughes RA Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199 [TBL] [Abstract][Full Text] [Related]
25. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637 [TBL] [Abstract][Full Text] [Related]
26. Enhancing Methotrexate Tolerance with Folate Tagged Liposomes in Arthritic Mice. Nogueira E; Lager F; Le Roux D; Nogueira P; Freitas J; Charvet C; Renault G; Loureiro A; Almeida CR; Ohradanova-Repic A; Machacek C; Bernardes GJ; Moreira A; Stockinger H; Burnet M; Carmo AM; Gomes AC; Preto A; Bismuth G; Cavaco-Paulo A J Biomed Nanotechnol; 2015 Dec; 11(12):2243-52. PubMed ID: 26510317 [TBL] [Abstract][Full Text] [Related]
27. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Fransen J; Laan RF; Van Der Laar MA; Huizinga TW; Van Riel PL Ann Rheum Dis; 2004 Oct; 63(10):1222-6. PubMed ID: 15361375 [TBL] [Abstract][Full Text] [Related]
28. (Bi)Weekly folic acid supplementation might be inferior to a daily folic acid dosing schedule in the prevention of methotrexate-related toxicity in patients with rheumatoid arthritis. van den Bemt BJ; den Broeder AA; Van der Burgt M; Fransen J; van Ede AE; van den Hoogen FH Clin Exp Rheumatol; 2015; 33(5):767-8. PubMed ID: 26316162 [No Abstract] [Full Text] [Related]
29. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. Morgan SL; Baggott JE; Lee JY; Alarcón GS J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760 [TBL] [Abstract][Full Text] [Related]
30. Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study. Koh KT; Teh CL; Cheah CK; Ling GR; Yong MC; Hong HC; Gun SC Reumatismo; 2016 Sep; 68(2):90-6. PubMed ID: 27608797 [TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248 [TBL] [Abstract][Full Text] [Related]
32. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200 [TBL] [Abstract][Full Text] [Related]
33. [Methotrexate and folates in rheumatoid arthritis]. Endresen GK; Husby G Tidsskr Nor Laegeforen; 1999 Feb; 119(4):534-7. PubMed ID: 10081378 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Stamp LK; Chapman PT; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Kennedy MA; Roberts RL Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493 [TBL] [Abstract][Full Text] [Related]
35. [Methotrexate treatment of rheumatoid arthritis]. Beyeler C Schweiz Med Wochenschr; 1996 Apr; 126(17):703-12. PubMed ID: 8668981 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. Kent PD; Luthra HS; Michet C J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491 [TBL] [Abstract][Full Text] [Related]
37. [The effect of comedication with folic or folinic acid on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double blind, placebo controlled study of 48 weeks]. Jansen TL; Spoorenberg A; Houtman PM; van Roon EN Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2168; author reply 2168. PubMed ID: 12474559 [No Abstract] [Full Text] [Related]
38. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil]. Sergiets NA; Erov NK Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190 [TBL] [Abstract][Full Text] [Related]
39. Methotrexate treatment and mortality in rheumatoid arthritis. Slot O Lancet; 2002 Oct; 360(9339):1095; author reply 1097-8. PubMed ID: 12384008 [No Abstract] [Full Text] [Related]
40. Severe acute pancytopaenia in a patient with rheumatoid arthritis complicated by fatal invasive pulmonary aspergillosis. Mortensen KL; Krogh TP; Jensen-Fangel S; Hauge EM Scand J Rheumatol; 2017 May; 46(3):249-250. PubMed ID: 27575284 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]